Multiple-variable dose regimen for treating TNFalpha-related disorders

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFa-RELATED DISORDERS Abstract Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose met...

Full description

Saved in:
Bibliographic Details
Main Authors Hoffman, Rebeca S, Granneman, George Richard, Philip Yan, Chartash, Elliot, Taylor, Lori K
Format Patent
LanguageEnglish
Published 22.12.2016
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFa-RELATED DISORDERS Abstract Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF inhibitor is administered in a higher dosage during the induction phase.
Bibliography:Application Number: AU20130204275